Alcidion Group Limited · ASX:ALC

Alcidion — Investor Presentation (May 2017)

19 slides from Alcidion's investor presentation, May 29, 2017

  1. Slide 1: Alcidion Investor Presentation May 2017

    For personal use only Alcidion Group Limited Alcidion Investor Presentation May 2017 1

  2. Slide 2: Disclaimer

    DISCLAIMER Disclaimer For personal use only This presentation has been prepared by Alcidion Group Limited (the "Company"). It does not purport to contain all the information that a prospective investor may require in connection with any potential investment in the Company. You should not treat the c

  3. Slide 3: ASX Ticker ALC corporate snapshot

    ASX Ticker ALC Market Capitalisation $45 million For personal use only 38% Founders Ownership 14% BlueSky Private Equity 5% Owned by Employees Share Price 7.40c Share Range (12 Months) 4.00c  14.00c Share Volume (12 Months) 148m Shares (TTM) Cash on hand $5.73 million Enterprise Value $36 million S

  4. Slide 4: Why is digital health such an exciting investment opportunity?

    WHY IS DIGITAL HEALTH SUCH AN EXCITING INVESTMENT OPPORTUNITY ? For personal use only ● The global population is aging, resulting in a dramatic and unparalleled increase in population, complex patients with multiple co-morbidities. ● The United States spends 18% of GDP on Healthcare, representing ov

  5. Slide 5: Why is digital health such an exciting investment opportunity?

    WHY IS DIGITAL HEALTH SUCH AN EXCITING INVESTMENT OPPORTUNITY ? For personal use only ● The Patient Protection & Affordable Care in 2010, mandated that all US hospitals upgrade their Clinical Information Systems. ● This HITECH Act stipulates that healthcare providers must demonstrate the meaningful

  6. Slide 6: The stars are aligning for digital health

    THE STARS ARE ALIGNING FOR DIGITAL HEALTH For personal use only ● FDA Regulating the environment. ● The Global Governments are allocating funds to Digital Health: – The United States government has set aside more than $USD20 billion in stimulus funds to implement Electronic Health Records nationwide

  7. Slide 7: Testimonial: Professor Tissa Wijerante, Western Health

    For personal use only “This has skyrocketed the efficiency in patient care as well as the safety” Professor Tissa Wijerante Consulting Neurologist Director of the Stroke & Neuroscience Unit Western Health 8

  8. Slide 8: Testimonial: Jason Whakaari, Western Health

    For personal use only “You’ll see nearly all of the clinical, executive and divisional directors walking around with the bed management views on their iPads, and the same with the bed management staff, the quality managers, the NUMs and any staff that help move the patients around.” Jason Whakaari E

  9. Slide 9: Executive Directors

    For personal use only EXECUTIVE DIRECTORS Chief Medical Officer Non-Executive Director Chief Executive Officer Executive Director Non-Executive Director Prof. Malcolm Pradhan Mr. Brian Leedman Mr. Ray Blight Mr. Nathan Buzza Mr. Nick Dignam • Formal qualifications in • Formal qualifications include

  10. Slide 10: What does Alcidion do?

    For personal use only WHAT DOES ALCIDION DO ? ● Hospitals are built upon a complex eco-system of disparate Clinical Information Systems. ● Alcidion’s Miya platform integrates disparate Clinical Information Systems to identify emerging clinical risk and push this clinical intelligence to the care tea

  11. Slide 11: What does Alcidion do?

    For personal use only WHAT DOES ALCIDION DO ? ● The technology is already deployed and operational at: – Western Health (3 Hospitals). – Northern Territory Health Department (5 Hospitals). – Tasmania Health (4 Hospitals). – Royal Melbourne Hospital. – Coffs Harbour Base Hospital. – Sunshine Coast Un

  12. Slide 12: Highlights past year

    For personal use only HIGHLIGHTS PAST YEAR ● Listed Alcidion on the ASX on February 29 2016, with $7m in cash, with minimal debt. ● Posted two consecutive cashflow positive quarters for Q1 and Q2 in FY17, with total cash of $5.75m (plus R&D Tax Provision of $576k) ● Commenced our commercialiation st

  13. Slide 13: Highlights past year

    For personal use only HIGHLIGHTS PAST YEAR ● Invested $1.5m developing a Computerized Physician Order Entry (CPOE) platform, in the form of a Best Practice Pathology Ordering product that automates the electronic ordering of pathology for ED physicians. ● Tasmania’s Northern Integrated Care Service

  14. Slide 14: Unique opportunity to be part of the new digital health economy

    Unique Opportunity To Be Part of the New Digital Health Economy For personal use only The introduction of the Patient Protection & Affordable Care Act requires US hospitals to adopt Electronic Medical Records or face a reduction in Medicare reimbursements. 15

  15. Slide 15: Experienced management team

    Experienced Management Team For personal use only “Capable and Experienced Management Team with a strong track record of commercializing healthcare software, including the former CEO & Chairman of the South Australian Health Commission, a Stanford qualified Medical Doctor and a former Ernst & Young

  16. Slide 16: Proven technology

    Proven Technology For personal use only Alcidion’s platform is installed into 15 large tertiary hospitals including Footscray, Sunshine, Williamstown, Royal Darwin & Alice Springs Hospitals and throughout Tasmania. 17

  17. Slide 17: Disruptive technology platform

    Disruptive Technology Platform For personal use only The platform is at the forefront of medical technology, on the crest of the next generation of healthcare technologies. 18

  18. Slide 18: Strong growth platform

    Strong Growth Platform For personal use only The business recently secured a $2.35m Contract with Western Health to adopt its Patient Flow Solutions across its three locations. 19

  19. Slide 19: Fully funded

    Fully Funded For personal use only The company is fully funded, with $5.73m in cash and minimal debt, with two quarters of positive cashflow. 20

Alcidion Group — Investor Presentation (May 2017) on 6ix